Olivier Nolan-Stevaux
Gilead Sciences (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immunotherapy and Immune Responses, Prostate Cancer Treatment and Research, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → A revised picture of the E2F transcriptional network and RB function(2002)425 cited
- → GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation(2009)377 cited
- → Native E2F/RBF Complexes Contain Myb-Interacting Proteins and Repress Transcription of Developmentally Controlled E2F Target Genes(2004)284 cited
- → Cell cycle-dependent and cell cycle-independent control of transcription by theDrosophilaE2F/RB pathway(2003)241 cited
- → Functional antagonism between E2F family members(2001)168 cited
- → Targeting Multiple Myeloma with AMG 424, a Novel Anti-CD38/CD3 Bispecific T-cell–recruiting Antibody Optimized for Cytotoxicity and Cytokine Release(2019)123 cited
- → Immunotherapy combinations overcome resistance to bispecific T cell engager treatment in T cell–cold solid tumors(2021)110 cited
- → Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies(2012)109 cited
- → Distinct mechanisms of E2F regulation by Drosophila RBF1 and RBF2(2002)102 cited
- → The PSMA-targeting Half-life Extended BiTE Therapy AMG 160 has Potent Antitumor Activity in Preclinical Models of Metastatic Castration-resistant Prostate Cancer(2021)89 cited